Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Therapeutic Discovery

Determinants of Mitotic Catastrophe on Abrogation of the G2 DNA Damage Checkpoint by UCN-01

Kin Fan On, Yue Chen, Hoi Tang Ma, Jeremy P.H. Chow and Randy Y.C. Poon
Kin Fan On
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yue Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hoi Tang Ma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy P.H. Chow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Randy Y.C. Poon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-10-0809 Published May 2011
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Uncoupling of the G2 DNA damage checkpoint by UCN-01. A, UCN-01 can induce precocious cell cycle progression in damaged cells. HeLa cells were irradiated and incubated for 16 hours. The cells were then treated with caffeine, UCN-01, and RO3306 as indicated. After 12 hours, the cells were fixed and analyzed by flow cytometry. B, cells were treated as shown in A. Cell-free extracts were prepared and the expression of the indicated proteins was detected by immunoblotting. Equal loading of lysates was confirmed by immunoblotting for actin. C, unscheduled mitotic entry after CHK1 depletion. HeLa cells were transfected with control or CHK1 siRNA. After 6 hours, the cells were irradiated, grown for 28 hours, and analyzed by flow cytometry. D, cells were treated as shown in C. Lysates were prepared analyzed by immunoblotting.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Various cell fates are induced by UCN-01. A, mitotic catastrophe and survival after UCN-01 challenge. HeLa cells expressing histone H2B-GFP and mRFP1-APC/C biosensor were untreated (n = 62), irradiated and grown for 16 hours (n = 66), UCN-01–treated (n = 48), or irradiated (16 hours) followed by UCN-01 treatment (n = 62). The cells were then subjected to time-lapse microscopy to track individual cells for 12 hours. Gray, interphase; black, mitosis (from DNA condensation to anaphase) or mitotic catastrophe; truncated bars, cell death. The time of cell death after mitosis is defined by the death of one of the daughters. The percentages of cells that completed mitosis or underwent mitotic catastrophe (MC) are shown [a portion of cells that were still trapped in an extremely long mitosis at the end of the 12-hour imaging was also categorized as MC—longer imaging revealed that they subsequently also underwent apoptosis (data not shown)]. B, Representative still images from time-lapse microscopy of IR- and UCN-01–treated cells. Cells were treated and imaged as shown in A. An example of a cell that could complete mitosis is shown. The full video can be found in Supplementary data (Supplementary Video S2). C, mitosis is extended in UCN-01–treated cells. Cells were treated and imaged as shown in A. The duration of mitosis in control (n = 50), cells treated with IR (n = 7, only a very small number of cells could enter mitosis), or IR followed by UCN-01 (n = 35) are shown (mean ± 90% CI). D, anaphase is delayed in UCN-01–induced mitosis. Control (n = 50) or IR- and UCN-01–treated cells (n = 35) were analyzed by time-lapse microscopy as shown in A. The time of prometaphase–metaphase and metaphase–anaphase was quantified (mean ± 90% CI).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Both the onset and extent of mitotic catastrophe are dependent on the level of DNA damage. A, high dose of IR prohibits UCN-01–induced G1 entry. HeLa cells were irradiated (15 or 40 Gy), grown for 16 hours, and treated with UCN-01 as indicated. At 12 and 24 hours after UCN-01 addition, DNA contents were analyzed by flow cytometry. B, dose-dependent activation of CHK1. HeLa cells were irradiated (15 or 40 Gy), grown for 16 hours, and treated with UCN-01 as indicated. Nocodazole was included to trap checkpoint-bypassed cells in mitosis. At the indicated time points after UCN-01 addition, the cells were harvested and analyzed by immunoblotting. C, Delayed mitotic entry and massive mitotic catastrophe after IR (40 Gy) and UCN-01 treatment. Cells were treated with IR (40 Gy) followed by UCN-01 as shown in A. Time-lapse microscopy was used to track individual cells for 12 hours. Key and definition are the same as given in Fig. 2A (n = 50). D, massive mitotic catastrophe in cells treated with IR (40 Gy) and UCN-01. Cells were treated with IR (40 Gy), UCN-01, and analyzed as shown in A (n = 50). Cells that completed mitosis without dying (mitosis), die during mitosis (mitotic catastrophe), or did not enter mitosis throughout the imaging period (interphase) were quantified (mean ± SD of 3 experiments).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Expression of p31comet attenuates UCN-01–mediated mitotic catastrophe. A, mitosis induced by checkpoint bypass is abolished by p31comet. FLAG-p31comet/HeLa cells were grown in the absence or presence of doxycycline for 30 hours to turn on or off the expression of FLAG-p31comet, respectively. They were treated with IR (16 hours) followed by UCN-01 (12 hours) as indicated. Lysates were prepared and analyzed by immunoblotting. B, p31comet suppresses UCN-01–mediated cell death. Cells were treated as shown in A. Cell viability was determined with trypan blue exclusion analysis (mean ± SD of 3 experiments). C, expression of MAD2 shRNA or p31comet suppresses mitotic catastrophe. HeLa cells expressing histone H2B-GFP were transfected with control vector (n = 50), plasmids expressing FLAG-p31comet (n = 52), or MAD2 shRNA (n = 74) together with a YFP marker. The cells were irradiated, grown for 16 hours, before treated with UCN-01. Time-lapse microscopy was used to track individual cells for 12 hours. Key and definition are the same as given in Fig. 2A.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Mitotic catastrophe can be promoted by delaying mitotic exit. A, downregulation of CDC20 and p31comet. HeLa cells were transfected with control or siRNAs against CDC20 or p31comet. Lysates were prepared and analyzed by immunoblotting (asterisks, phosphorylated forms of BUBR1 and CDC27). B, depletion of CDC20 inhibits mitotic exit. HeLa cells were transfected with either control or CDC20 siRNA. After 6 hours, the cells were irradiated, grown for 16 hours, and treated with UCN-01. After 12 hours, DNA contents were analyzed with flow cytometry. C, downregulation of CDC20 or p31comet enhances mitotic catastrophe. HeLa cells expressing histone H2B-GFP and mRFP1-APC/C biosensor were transfected with control siRNA (n = 50), CDC20 siRNA (n = 68), or p31comet siRNA (n = 74). The cells were irradiated, grown for 16 hours, and treated with UCN-01. Individual cells were tracked with time-lapse microscopy for 12 hours. Key and definition are the same as given in Fig. 2A.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Different cell lines display different susceptibility to mitotic catastrophe. A, the unperturbed mitotic length of different cell lines. The indicated cell lines, which expressed histone H2B-GFP, were subjected to time-lapse microscopy. Mitosis length in individual cells was analyzed (n = 50, mean ± 90% CI). B, mitotic length after checkpoint abrogation. The indicated histone H2B-GFP-expressing cell lines were irradiated (15 Gy), grown for 16 or 24 hours (for U2OS and NIH3T3), and treated with UCN-01. Individual cells were tracked with time-lapse microscopy (n = 50) to analyze the duration of mitosis (mean ± 90% CI). C, different cell lines exhibit different susceptibility to mitotic catastrophe. The indicated histone H2B-GFP–expressing cell lines were transfected with control or CDC20 siRNA. The cells were irradiated with either 15 or 40 Gy, grown for 16 or 24 hours (for U2OS and NIH3T3), and treated with UCN-01. Mitotic catastrophe was analyzed by time-lapse microscopy (12 hours, n = 50).

Additional Files

  • Figures
  • Supplementary Data, On, et al.

    Files in this Data Supplement:

    • Supplementary Figures 1-8
    • Supplementary Video and Figure Legends
    • Supplementary Video 1
    • Supplementary Video 2
    • Supplementary Video 3
    • Supplementary Video 4
    • Supplementary Video 5
    • Supplementary Video 6
    • Supplementary Video 7
    • Supplementary Video 8
    • Supplementary Video 9
    • Supplementary Video 10
PreviousNext
Back to top
Molecular Cancer Therapeutics: 10 (5)
May 2011
Volume 10, Issue 5
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Determinants of Mitotic Catastrophe on Abrogation of the G2 DNA Damage Checkpoint by UCN-01
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Determinants of Mitotic Catastrophe on Abrogation of the G2 DNA Damage Checkpoint by UCN-01
Kin Fan On, Yue Chen, Hoi Tang Ma, Jeremy P.H. Chow and Randy Y.C. Poon
Mol Cancer Ther May 1 2011 (10) (5) 784-794; DOI: 10.1158/1535-7163.MCT-10-0809

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Determinants of Mitotic Catastrophe on Abrogation of the G2 DNA Damage Checkpoint by UCN-01
Kin Fan On, Yue Chen, Hoi Tang Ma, Jeremy P.H. Chow and Randy Y.C. Poon
Mol Cancer Ther May 1 2011 (10) (5) 784-794; DOI: 10.1158/1535-7163.MCT-10-0809
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Grant Support
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Glucocorticoid Receptor Signals in Bladder Cancer Cells
  • Ligand Systemic Targeting of the Grp78 Promoter
  • Sorafenib Targets VCP in Hepatocellular Cancer Cells
Show more Therapeutic Discovery
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement